Match Document Document Title
US20120028879 HIGHLY SENSITIVE DETECTION METHOD FOR HIGHLY VIRULENT ORAL CAVITY BACTERIA  
Provided is a method that involves the detection of protein antigen (PA) and/or collagen-binding protein (CBP) of oral cavity bacteria in a sample, and in which oral cavity bacteria that...
US20120276145 EXTRACELLULAR MATRIX PROTEINS FROM HAEMOPHILUS INFLUENZAE BIOFILMS: TARGETS FOR THERAPEUTIC OR DIAGNOSTIC USE  
A method of identifying a biofilm that includes non-typeable Haemophilus influenza (NTHi) including a step of screening a sample for the presence of one or more biofilm-specific proteins that are...
US20130035283 ENGINEERED OPSONIN FOR PATHOGEN DETECTION AND TREATMENT  
The present invention provides for engineered molecular opsonins that may be used to bind biological pathogens or identify subclasses or specific pathogen species for use in devices and systems...
US20120077767 MOLECULAR PREDICTORS OF FUNGAL INFECTION  
Methods for identifying fungal infection, assays for identifying genomic and protein markers of fungal infection, and methods for diagnosing the fungal infection. In one aspect, the method of...
US20140113305 EXOSOMES AND DIAGNOSTIC BIOMARKERS  
The invention provides methods for the detection of M. tuberculosis proteins in or on exosomes derived from infected individuals. The methods can use a proteomic approach including mass...
US20150238591 Multifunctional Oral Vaccine Based on Chromosome Recombineering  
A recombineered Salmonella typhi Ty21a, compositions and vaccines comprising such a Ty21a, and a method for recombineering comprising inserting a large antigenic region into a bacterial chromosome...
US20130266939 SYSTEMS AND METHODS FOR STUDYING INFLAMMATION-DRUG INTERACTIONS  
The present disclosure provides compositions, systems, and tools for modeling liver inflammation and methods of using the same. The disclosure provides micropatterned hepatocyte co-cultures where...
US20150168378 RETINAL PIGMENT EPITHELIAL PRIMARY CELL CULTURE SYSTEM PRODUCING SUBCELLULAR DEPOSITS  
The present invention provides a retinal pigment epithelial (RPE) primary cell culture system on a material surface seeded at a high density that produces a layer of subcellular deposits, wherein...
US20120264164 LYMPH NODE SPECIMEN COLLECTION KIT AND METHOD OF PATHOLOGICAL ANALYSIS FOR LUNG CANCER DIAGNOSIS USING SUCH A KIT  
A unique system for the correlation between removed lymph nodes for lung cancer diagnosis and pathological analysis thereof is provided. Such a system includes the removal of certain lymph nodes...
US20130210031 DETECTION OF ADENYLATE CYCLASE  
One major problem in diagnosis methods presently available for anthrax is that these methods require several days to produce a result, are rendered unusable after antibiotic use, or are not...
US20140335536 VACCINE FOR THE TREATMENT OF MYCOBATERIUM RELATED DISORDERS  
The invention relates to genes and proteins involved in the sporulation of Mycobacteria and the use thereof in the technical fields of immunology and medicine.
US20130260411 Modular compositing screening protocols  
Multiple samples are taken from multiple units of food product to be tested for pathogen or other microbes, with the samples being pooled for composite testing, individual testing being required...
US20130095521 METHOD FOR TESTING AND MONITORING THE STERILITY OF PLANT PRODUCTION UNITS  
The present invention relates to a method for testing the sterility of a plant by checking for the presence and identifying at least one microorganism.
US20150185224 PREDICTING BLADDER CANCER RESPONSIVENESS TO BCG  
Bacillus Calmette-Guerin (BCG) administration plays a central role in managing carcinoma in situ of the bladder. Unfortunately, recurrence or progression of disease is seen in up to 30% of treated...
US20120064105 Engineered Type IV Pilin of Clostridium difficile  
The present invention relates to engineered Clostridium difficile type IV pilin (tfp) genes, type IV pilin proteins which can serve as a diagnostic marker for identification of patients infected...
US20110117595 Testing Unit and Method for Testing a Sterilization Packaging Unit  
A testing unit and a method of testing a sterilization packaging unit for microbial contamination of sterilized objects after they have been sterilized are disclosed. The testing unit includes a...
US20140127743 METHODS FOR PRODUCING RECOMBINANT PROTEINS  
Methods for producing recombinant cell populations are disclosed. The disclosed methods may be used to produce therapeutic polyclonal proteins.
US20120302464 METHODS FOR PRODUCING RECOMBINANT PROTEINS  
Methods for producing recombinant cell populations are disclosed. The disclosed methods may be used to produce therapeutic polyclonal proteins.
US20130172430 PROGNOSIS AND TREATMENT OF BREAST CANCER  
Methods of prognosis and monitoring of breast cancer include determining the level of one or more of the markers comprising asymmetric dimethyl arginine (ADMA), beta-hydroxybutyrate (BHB) and...
US20140314876 PROTEOMICS BASED DIAGNOSTIC DETECTION METHOD FOR CHRONIC SINUSITIS  
The invention provides for a proteomic approach for identification of specific bacterial protein profiles that may be used in the development of methods for the diagnosis of bacterial chronic...
US20140315212 ALPHA TOXIN DETECTION OF GPI ANCHORED PROTEINS  
The present invention relates to a method for the purification, concentration and identification of glycosylphosphatidylinositol anchored proteins (GPI-APs) from a biological sample (cells,...
US20150104819 METHODS OF USING ISONIAZID FOR THE DIAGNOSIS OF LUNG INFECTIONS  
The present invention is directed to methods of diagnosing the presence or absence of a bacterial infection in a patient, in particular, a tuberculosis infection, by measuring exhaled,...
US20140120122 METHOD FOR MONITORING VACCINE RESPONSE USING SINGLE CELL NETWORK PROFILING  
The present invention provides methods for determining safety and efficacy of a vaccine by monitoring cellular pathways prior to and after vaccine treatment using single cell network profiling
US20130210069 BIOLOGICAL STERILIZATION INDICATOR SYSTEM AND METHOD  
A biological sterilization indicator (BI) system and method. The system can include a BI and a reading apparatus comprising a well. The BI can include a housing, which can include a first portion,...
US20140302550 CULTURE MEDIUM KIT AND METHOD FOR DETECTION OF MICROORGANISMS  
The present invention discloses culture medium unit doses for cultivating microorganisms comprising at least two compositions, each composition packaged in a composition unit dose of a...
US20140115730 Apparatuses and Methods for Evaluating and Sorting Pollen and Plants  
A method for sorting pollen containing genetic elements of interest may include associating a genetic marker with seeds defining the genetic elements of interest, growing plants from the seeds,...
US20140044673 Classifying Skin Lesions Using Mass Spectrometry Proteomic Approach  
The present invention provides for a mass spectrometry proteomic approach to distinguishing Spitz nevi from Spitzoid malignant melanoma. Histology directed mass spectral profiling allows for...
US20130065835 PROGNOSTIC TESTS FOR DEVELOPMENT OF DERMAL STRETCH MARKS AND IMPLICATIONS FOR THE PREVENTATIVE TREATMENT THEREOF  
Various methods of assessing the regenerative potential of dermal tissue in a patient may be determined and methods to determine the potential development of stretch marks in a patient are...
US20110262927 ANALYZING BACTERIA WITHOUT CULTURING  
The invention generally relates to conducting an assay on a sample that isolates a pathogen from the sample and allows for analysis of the pathogen with minimal (i.e., at most 24 hrs of culturing)...
US20120003686 CULTURE PLATE HOLDER  
The present disclosure describes holder devices, testing kits that include the holder devices, and methods for using the holder devices to allow a user to dispense an aqueous test sample from a...
US20110275089 Methods for predicting survival in metastatic melanoma patients  
Cellular and genetic signatures and methods of using same for subcategorizing stage III melanoma tumors are described herein. The signatures and methods are particularly useful with regard to...
US20140255983 METHOD OF CANCER DIAGNOSIS USING THE ANALYSIS OF ISOTOPES  
Disclosed is a method of diagnosing cancer on the basis of the quantitative analysis of blood or tissue isotopes, for example, such as 36S or 40K. The method can accurately diagnose cancer in a...
US20140255982 METHOD OF CANCER DIAGNOSIS USING THE ANALYSIS OF ISOTOPES  
Disclosed is a method of diagnosing cancer on the basis of the quantitative analysis of blood or tissue isotopes, for example, such as 36S or 40K. The method can accurately diagnose cancer in a...
US20140255981 METHOD OF CANCER DIAGNOSIS USING THE ANALYSIS OF ISOTOPES  
Disclosed is a method of diagnosing cancer on the basis of the quantitative analysis of blood or tissue isotopes, for example, such as 36S or 40K. The method can accurately diagnose cancer in a...
US20140212907 Methods and Kits for Measuring Toxicity and Oxidative Stress in Live Cells  
Compositions and methods for the measuring toxicity, antioxidant capacity, and oxidative stress are provided.
US20130224737 Method For Determining The Production Of Reactive Oxygen Species In A Cellular Population  
The invention relates to a method for determining the production of reactive oxygen species in a cellular population. The invention also relates to a method for determining the need for an...
US20080268446 Flexible Culture Medium Bag Containing Nutrient Concentrate  
Disclosed is a culture medium container such as a bag comprising a main compartment and a locus of containment that contains a nutrient concentrate until it is released at the time of use. The...
US20110014645 METHOD FOR DETERMINING A COMPLETE BLOOD COUNT ON A WHITE BLOOD CELL DIFFERENTIAL COUNT  
Systems and methods analyzing body fluids such as blood and bone marrow are disclosed. The systems and methods may utilize an improved technique for applying a monolayer of cells to a slide to...
US20130259807 CELL CULTURE SCREEN FOR AGENTS THAT CONTROL ADIPOGENESIS AND MYOFIBROBLAST DIFFERENTIATION  
Methods are provided for the rapid and robust screening test agents for adipogenic activity. Agents testing positive in the assays are good candidate agents for wrinkle reduction, normalizing skin...
US20150056606 TISSUE TESTER  
A tissue tester for providing an indication of the presence of disease including a first paper tissue sheet; and a filter patch treated with a color changing indicator affixed to the first paper...
US20110086064 COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN  
Screening and diagnostic reagents, kits and methods for metastatic colorectal cancer or primary and/or metastatic stomach or esophageal cancer are disclosed. Vaccines compositions and methods of...
US20150086971 AUTOMATED SELECTION OF MICROORGANISMS AND IDENTIFICATION USING MALDI  
A method and apparatus for locating and selecting a colony of microorganisms on a culture dish and identifying microorganisms in said selected colony using MALDI. The method comprises the...
US20150168380 MIXTURE OPHTHALMIC STRIPS  
This invention is within the field of eye medicine, involving the preparation method of one type of cornea intravital staining. The above mentioned staining includes the mixed solution of...
US20120237967 Method for Microbiological Testing  
Costly enrichment medium used for microbiological testing of nuts and other moisture-absorbing food products is conserved by saturating the product with water or other inexpensive liquid prior to...
US20080261264 Culture Medium for Detecting of Clostridium Perfringens  
The invention relates to a culture medium for the detection of Clostridium perfringens. The invention consists in: dissolving protease peptone, microbiological peptone, yeast extract, sodium...
US20120115181 SYSTEMS AND METHODS FOR CEREBROSPINAL FLUID COLLECTION  
A test tube insert includes a flange having a width greater than a width of a mouth of a larger test tube into which the insert is to be inserted. The flange defines a first central opening. An...
US20120284046 Computer program product for reporting a result of an evaluation of a sample after queuing the result for transmission  
A computer program product includes a recordable-type signal bearing medium bearing computer usable code configured for causing an automatic evaluation, remotely from a health care facility, of a...
US20140356318 ADOPTIVE CELL THERAPY WITH SPECIFIC REGULATORY LYMPHOCYTES  
The present invention comprises a method of treatment of an autoimmune disease involving a specific tolerance induction (“STI”) event, wherein the method includes: collecting a first sample from...
US20130171686 METHOD OF TREATING MINE-INFLUENCED WATER AND SOIL  
The present invention is directed to a method of trans-seasonal bioremedial treating of mine-influenced water and soil (MIWAS) in situ with microorganisms for removal of contaminants containing...
US20150017638 METHODS FOR ASSESSING RISK FOR CANCER USING BIOMARKERS  
The present disclosure is directed to methods and kits for detecting, characterizing, preventing, and treating cancer, e.g., pancreatic cancer, or inflammation, by determining the presence of...